Page last updated: 2024-08-21

adamantane and oseltamivir

adamantane has been researched along with oseltamivir in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (45.45)	29.6817
2010's	11 (50.00)	24.3611
2020's	1 (4.55)	2.80

Authors

Authors	Studies
Moscona, A	1
Linder, JA	1
Barr, IG; Deed, N; Hurt, AC; Iannello, P; Komadina, N; Tomasov, C	1
Campbell, JD	1
Guralnick, RP; Habib, F; Hill, AW; Janies, D; Wilson, MJ	1
Jacobson, RM; Ovsyannikova, IG; Poland, GA	1
Cilla, G; Mendiola, J; Montes, M; Pérez-Trallero, E; Vicente, D	1
Hannongbua, S; Intharathep, P; Kaiyawet, N; Malaisree, M; Nunthaboot, N; Payungporn, S; Poovorawan, Y; Rungrotmongkol, T; Sompornpisut, P	1
Agudo, R; Barrantes, M; Comach, G; de Rivera, I; Douce, R; García, J; Gomez, J; Jimenez, M; Kochel, T; Sanchez, F; Sovero, M; Torres, AL	1
Abughali, N; Abzug, MJ; Bradley, JS; Cloud, GA; Englund, J; Griffin, J; Guzman-Cottrill, J; Jacobs, RF; Jester, P; Kimberlin, DW; Lang, D; Leach, C; Ramilo, O; Robinson, J; Romero, JR; Shalabi, M; Shelton, M; Storch, G; Wade, KC; Whitley, RJ	1
Beekmann, SE; Dharan, NJ; Finelli, L; Fiore, A; Fry, AM; Polgreen, PM; Uyeki, TM	1
de Jong, MD; Hayden, FG	1
Bullion, L; Deyde, VM; Fry, AM; Garten, RJ; Gubareva, LV; Klimov, AI; Li, Y; Peebles, PJ; Sheu, TG; Shwe, T	1
Deyde, VM; Fry, AM; Garten, RJ; Gubareva, LV; Klimov, AI; Mishin, VP; Nguyen, HT; Okomo-Adhiambo, M; Shaw, MW; Sheu, TG; Sleeman, K; Trujillo, AA	1
Alcantara-Perez, P; Alpuche-Aranda, C; Barrera-Badillo, G; Cordova Villalobos, JA; Cortez-Ortiz, I; Díaz-Quiñonez, JA; Gatell-Ramírez, HL; Gonzalez-Duran, E; Gubareva, L; Hernández-Avila, M; Lezana-Fernández, MA; Lopez-Martinez, I; Nguyen, H; Olivera-Diaz, H; Ramirez-Gonzalez, JE; Wong-Arambula, C	1
Hou, N; Jonges, M; Ke, C; Koopmans, M; Li, H; Liao, J; Meijer, A; Ni, H; Wang, Y; Wu, J; Zhang, X; Zhou, J; Zou, L	1
Boucher, CA; Collins, PJ; Gamblin, SJ; Haire, LF; Hay, AJ; Liu, J; Martin, SR; Osterhaus, AD; Schutten, M; Skehel, JJ; Vachieri, SG; van der Vries, E; Walker, PA; Xiong, X	1
Aris-Brosou, S; Garcia, V	1
Hurt, AC	1
Bahl, J; Baranovich, T; Culhane, M; Darnell, D; Govorkova, EA; Kaplan, BS; Lowe, JF; Marathe, BM; Stigger-Rosser, E; Webby, RJ	1
Cheng, Y; Cui, M; Ding, Y; He, W; Li, L; Li, X; Li, Z; Tian, A; Yang, C; Zhao, Z; Zou, X	1

Reviews

3 review(s) available for adamantane and oseltamivir

Article	Year
Neuraminidase inhibitors for influenza. The New England journal of medicine, 2005, Sep-29, Volume: 353, Issue:13 Topics: Acetamides; Adamantane; Adult; Aged; Antiviral Agents; Child; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2005
Antiviral therapy and prophylaxis for influenza in children. Pediatrics, 2007, Volume: 119, Issue:4 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir	2007
The epidemiology and spread of drug resistant human influenza viruses. Current opinion in virology, 2014, Volume: 8 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation, Missense; Neuraminidase; Oseltamivir; Viral Proteins; Virulence	2014

Other Studies

19 other study(ies) available for adamantane and oseltamivir

Article	Year
Influenza-associated deaths among children. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Acetamides; Adamantane; Antiviral Agents; Child; Humans; Influenza, Human; Oseltamivir; United States	2006
Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral research, 2007, Volume: 73, Issue:2 Topics: Adamantane; Antiviral Agents; Australia; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; Rimantadine; Zanamivir	2007
Pandemic flu vaccine: are we doing enough? Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:6 Topics: Adamantane; Adjuvants, Immunologic; Animals; Antiviral Agents; Disease Outbreaks; Drug Approval; Drug Design; Drug Resistance, Viral; Enzyme Inhibitors; History, 20th Century; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Poultry; United States; United States Food and Drug Administration	2007
Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2009, Volume: 9, Issue:2 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Evolution, Molecular; Genome, Viral; Genotype; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; Reassortant Viruses; Selection, Genetic; Viral Matrix Proteins	2009
Influenza virus resistance to antiviral agents: a plea for rational use. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, May-01, Volume: 48, Issue:9 Topics: Adamantane; Animals; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Oseltamivir	2009
Rapid spread of drug-resistant influenza A viruses in the Basque Country, northern Spain, 2000-1 to 2008-9. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2009, May-21, Volume: 14, Issue:20 Topics: Adamantane; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation; Oseltamivir; Spain	2009
Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochemical and biophysical research communications, 2009, Jul-31, Volume: 385, Issue:3 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Viral Matrix Proteins	2009
Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza and other respiratory viruses, 2009, Volume: 3, Issue:2 Topics: Adamantane; Amino Acid Sequence; Animals; Antiviral Agents; Cell Line; Central America; Dogs; Drug Resistance, Viral; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Molecular Sequence Data; Neuraminidase; Orthomyxoviridae; Oseltamivir; Sequence Alignment; South America; Viral Matrix Proteins	2009
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. The Pediatric infectious disease journal, 2010, Volume: 29, Issue:3 Topics: Adamantane; Antiviral Agents; Central Nervous System; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Nervous System Diseases; Oseltamivir; Retrospective Studies; Rimantadine	2010
Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses. Antiviral research, 2010, Volume: 88, Issue:2 Topics: Adamantane; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Drug Utilization; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Rimantadine; Seasons; Surveys and Questionnaires; Zanamivir	2010
Emerging influenza antiviral resistance threats. The Journal of infectious diseases, 2011, Jan-01, Volume: 203, Issue:1 Topics: Adamantane; Antiviral Agents; Drug Resistance, Multiple, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation, Missense; Oseltamivir; Reassortant Viruses; Virus Replication	2011
Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. The Journal of infectious diseases, 2011, Jan-01, Volume: 203, Issue:1 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Multiple, Viral; Genome, Viral; Genotype; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation, Missense; Neuraminidase; Oseltamivir; RNA, Viral; Viral Matrix Proteins; Viral Proteins	2011
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antiviral therapy, 2010, Volume: 15, Issue:8 Topics: Acids, Carbocyclic; Adamantane; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Cyclopentanes; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Pyrans; Pyrrolidines; Sialic Acids; Viral Plaque Assay; Zanamivir	2010
Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico. Emerging infectious diseases, 2011, Volume: 17, Issue:2 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mexico; Microbial Sensitivity Tests; Neuraminidase; Oseltamivir; Pandemics; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Zanamivir	2011
Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009. Journal of clinical microbiology, 2011, Volume: 49, Issue:7 Topics: Adamantane; China; Cluster Analysis; Drug Resistance, Viral; Genotype; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Neuraminidase; Oseltamivir; Sequence Analysis, DNA; Viral Matrix Proteins; Viral Proteins	2011
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS pathogens, 2012, Volume: 8, Issue:9 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Binding Sites; Crystallography, X-Ray; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Pandemics; Protein Conformation; Zanamivir	2012
Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors. Molecular biology and evolution, 2014, Volume: 31, Issue:2 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Genome, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; United States; United States Food and Drug Administration; Viral Matrix Proteins	2014
Influenza A viruses of swine circulating in the United States during 2009-2014 are susceptible to neuraminidase inhibitors but show lineage-dependent resistance to adamantanes. Antiviral research, 2015, Volume: 117 Topics: Acids, Carbocyclic; Adamantane; Amino Acid Substitution; Animals; Antiviral Agents; Base Sequence; Cyclopentanes; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Genotype; Guanidines; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H1N2 Subtype; Influenza A Virus, H3N2 Subtype; Madin Darby Canine Kidney Cells; Mutation, Missense; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Phenotype; Phylogeny; Swine; Swine Diseases; Time Factors; United States; Viral Proteins; Zanamivir	2015
Anti-influenza virus activity of the REV-ERBα agonist SR9009 and related analogues. Antiviral research, 2022, Volume: 207 Topics: Adamantane; Antiviral Agents; ARNTL Transcription Factors; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Interferons; Oseltamivir; Pyrrolidines; Ribavirin; Thiophenes	2022